動物用医薬品の世界市場レポート 2025年

動物用医薬品の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で448億4,000万米ドルに成長します。予測期間の成長は、獣医医療における個別化医療、獣医学研究の世界化、獣医医療における遠隔医療の採用、気候変動の影響、人獣共通感染症への備えなどに起因すると考えられます。予測期間の世界の動向には、予防ヘルスケアへの注力、動物用医薬品の進歩、バイオテクノロジーとバイオ医薬品、デジタルヘルス技術、動物用医薬品の世界化、持続可能で倫理的な実践、規制遵守と安全性などが含まれます。

ペットの飼い主数の増加が動物用医薬品市場の成長を促進すると予想されます。ペットの飼い主とは、動物を所有または飼養し、その世話と健康に責任を持つ個人です。この責任が動物用医薬品の需要を促進し、動物用医薬品市場の拡大に寄与しています。例えば、米国を拠点とする非政府組織Shelter Animals Countは、2023年に、2022年と比較して犬の養子縁組数が10万9,000頭増加したと報告しており、養子縁組率の動向は良好であることを示しています。しかし、2023年の犬の養子縁組総数は前年より10万8000頭近く少ないままです。その結果、ペット飼育人口の増加が動物用医薬品市場を牽引しています。

ペット保険への需要の高まりが動物用医薬品市場の成長を促進すると予想されます。ペット保険は経済的保護の一形態であり、ペットのケアに関連する獣医費用をカバーし、飼い主のヘルスケア費用管理を支援します。ペット保険には、診断、治療、手術、投薬、入院など、動物用医薬品に不可欠なすべての要素が含まれています。2023年5月、北米ペット健康保険協会（NAPHIA）は、2022年に北米で536万匹のペットが保険に加入し、2021年の440万匹から21.7％増加したと報告しました。このようなペット保険の普及拡大は、動物用医薬品市場の重要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の動物用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の動物用医薬品市場：成長率分析
• 世界の動物用医薬品市場の実績：規模と成長, 2019-2024
• 世界の動物用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界の動物用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物用医薬品市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物
• ワクチン
• 医療用飼料添加物
• 世界の動物用医薬品市場：動物タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンパニオンアニマル
• 家畜
• 世界の動物用医薬品市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口投与
• 非経口経路
• 局所経路
• 世界の動物用医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院薬局
• 獣医薬局小売業
• 世界の動物用医薬品市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リファレンスラボ
• ポイントオブケア検査/院内検査
• 動物病院と診療所
• その他のエンドユーザー
• 世界の動物用医薬品市場：薬物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗菌剤
• 抗炎症薬
• 疼痛管理薬
• ホルモン剤
• 麻酔薬
• 世界の動物用医薬品市場：ワクチンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• DNAワクチン
• 多価ワクチン
• 世界の動物用医薬品市場：医療用飼料添加物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 栄養補助食品
• 抗菌飼料添加物
• プロバイオティクスとプレバイオティクス
• 酵素
• 成長促進剤

第7章 地域別・国別分析

• 世界の動物用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の動物用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用医薬品市場：競合情勢
• 動物用医薬品市場：企業プロファイル
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Dechra Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac
• Boehringer Ingelheim International GmbH
• Kindred Biosciences Inc.
• Biogenesis Bago SA
• Indian Immunologicals Limited
• Neogen Corporation
• Hester Biosciences Limited
• Phibro Animal Health
• Vetoquinol S.A.
• IDEXX Laboratories Inc.
• Heska Corporation
• Henry Schein Animal Health
• Patterson Companies Inc.
• Covetrus Inc.
• VetPartners

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物用医薬品市場2029：新たな機会を提供する国
• 動物用医薬品市場2029：新たな機会を提供するセグメント
• 動物用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary medicine is a branch of medicine dedicated to preventing, diagnosing, and treating diseases in animals. It is essential for ensuring the health and well-being of pets, livestock, and wildlife. Additionally, veterinary medicine contributes significantly to public health by managing zoonotic diseases.

The primary products within veterinary medicine include drugs, vaccines, and medical feed additives. Drugs are pharmacologically active substances administered to animals to address illness and enhance their health and growth. These medications are provided through oral, parental (injection), and topical (on the skin) routes of administration. They are distributed via diverse channels, including veterinary hospital pharmacies and retail veterinary pharmacies. These products cater to various end-users such as reference laboratories, point-of-care testing or in-house testing facilities, veterinary hospitals and clinics, among others. The animals benefiting from these medications span companion and livestock animals.

The veterinary medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary medicine market statistics, including veterinary medicine industry global market size, regional shares, competitors with a veterinary medicine market share, detailed veterinary medicine market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medicine industry. This veterinary medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary medicine market size has grown strongly in recent years. It will grow from $31.08 billion in 2024 to $33.29 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to advancements in veterinary science, rising awareness of zoonotic diseases, focus on animal welfare, globalization of pet trade, specialization in veterinary care, increased spending on pet healthcare.

The veterinary medicine market size is expected to see strong growth in the next few years. It will grow to $44.84 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine in veterinary care, globalization of veterinary research, telehealth adoption in veterinary care, climate change impact, zoonotic disease preparedness. Major trends in the forecast period include focus on preventive healthcare, advancements in animal pharmaceuticals, biotechnology and biopharmaceuticals, digital health technologies, globalization of veterinary medicine, sustainable and ethical practices, regulatory compliance and safety.

The rising number of pet owners is expected to fuel the growth of the veterinary medicine market. Pet owners are individuals who own or adopt animals and are responsible for their care and health. This responsibility drives demand for veterinary drugs and contributes to the expansion of the veterinary medicine market. For example, in 2023, Shelter Animals Count, a US-based non-governmental organization, reported an increase of 109,000 dog adoptions compared to 2022, showing a positive trend in adoption rates. However, the total number of dogs adopted in 2023 remains nearly 108,000 lower than the previous year. As a result, the growing population of pet owners is driving the veterinary medicine market.

The increasing demand for pet insurance is expected to fuel the growth of the veterinary medicine market. Pet insurance, a form of financial protection, covers veterinary costs associated with pet care, aiding pet owners in managing healthcare expenses. Pet insurance encompasses diagnostics, treatments, surgeries, medications, and hospitalization-all essential components of veterinary medicine. In May 2023, the North American Pet Health Insurance Association (NAPHIA) reported a notable increase, with 5.36 million pets insured in North America in 2022, reflecting a 21.7% rise from the 4.4 million in 2021. This growing adoption of pet insurance is a significant driver for the veterinary medicine market.

Leading companies in the veterinary medicine market are introducing innovative products, such as ethno-veterinary medicines, to gain a competitive advantage. Ethno-veterinary medicines are derived from Ayurvedic formulations and are designed to treat animal diseases. For example, in August 2023, Milma, an Indian dairy company, launched ethno-veterinary medicines as low-cost alternatives to allopathic veterinary drugs. These medicines provide a cost-effective solution for animal healthcare, helping reduce veterinary expenses for farmers and offering a simple, affordable, and farmer-friendly tool for prevention and treatment.

Key players in the veterinary medicine market are forming strategic partnerships to enhance research and development efforts. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in May 2023, ILC Therapeutics, a Scottish biotech company, partnered with Dechra Pharmaceuticals, a UK-based veterinary medicine group, to develop a treatment for canine atopic dermatitis, focusing on ILC's Caniferon product. This collaboration highlights the growing intersection between technology and animal healthcare, marking a significant advancement in veterinary medicine.

In September 2022, Zoetis, a US-based animal health company, acquired Jurox for an undisclosed sum. This acquisition aims to enhance Zoetis' portfolio of parasiticides and anti-infectives, broadening its range of animal health products and creating opportunities for further global expansion. Jurox, an Australian veterinary pharmaceutical manufacturer, specializes in providing veterinary medicines.

Major companies operating in the veterinary medicine market are Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Vetoquinol S.A., IDEXX Laboratories Inc., Heska Corporation, Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., VetPartners, National Veterinary Associates, Pathway Vet Alliance, VetCor, PetVet Care Centers, BluePearl Veterinary Partners, Banfield Pet Hospital, VCA Animal Hospitals, Mars Veterinary Health

North America was the largest region in the veterinary medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the veterinary medicine market report during the forecast period. The regions covered in the veterinary medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary medicine market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Drugs; Vaccines; Medical Feed Additives
• 2) By Animal Type: Companion Animals; Livestock Animals
• 3) By Route Of Administration: Oral Route; Parental Route; Topical Route
• 4) By Distribution Channel: Veterinary Hospital Pharmacies; Retail Veterinary Pharmacies
• 5) By End-Use: Reference Laboratories; Point-Of-Care Testing Or In-House Testing; Veterinary Hospitals And Clinics; Other End-users
• Subsegments:
• 1) By Drugs: Antimicrobials; Anti-inflammatory Drugs; Pain Management Drugs; Hormonal Drugs; Anesthetics
• 2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; DNA Vaccines; Multivalent Vaccines
• 3) By Medical Feed Additives: Nutritional Supplements; Antimicrobial Feed Additives; Probiotics And Prebiotics; Enzymes; Growth Promoters
• Companies Mentioned: Zoetis Inc.; Merck & Co. Inc.; Elanco Animal Health Incorporated; Dechra Pharmaceuticals PLC; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Medicine Market Characteristics

3. Veterinary Medicine Market Trends And Strategies

4. Veterinary Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Medicine Market Growth Rate Analysis
• 5.4. Global Veterinary Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Medicine Total Addressable Market (TAM)

6. Veterinary Medicine Market Segmentation

• 6.1. Global Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Vaccines
• Medical feed additives
• 6.2. Global Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animals
• Livestock Animals
• 6.3. Global Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral route
• Parental route
• Topical route
• 6.4. Global Veterinary Medicine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospital pharmacies
• Retail veterinary pharmacies
• 6.5. Global Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reference Laboratories
• Point-of-Care Testing/In-House Testing
• Veterinary Hospitals and Clinics
• Other End-users
• 6.6. Global Veterinary Medicine Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimicrobials
• Anti-inflammatory Drugs
• Pain Management Drugs
• Hormonal Drugs
• Anesthetics
• 6.7. Global Veterinary Medicine Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Multivalent Vaccines
• 6.8. Global Veterinary Medicine Market, Sub-Segmentation Of Medical Feed Additives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nutritional Supplements
• Antimicrobial Feed Additives
• Probiotics And Prebiotics
• Enzymes
• Growth Promoters

7. Veterinary Medicine Market Regional And Country Analysis

• 7.1. Global Veterinary Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Medicine Market

• 8.1. Asia-Pacific Veterinary Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Medicine Market

• 9.1. China Veterinary Medicine Market Overview
• 9.2. China Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Medicine Market

• 10.1. India Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Medicine Market

• 11.1. Japan Veterinary Medicine Market Overview
• 11.2. Japan Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Medicine Market

• 12.1. Australia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Medicine Market

• 13.1. Indonesia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Medicine Market

• 14.1. South Korea Veterinary Medicine Market Overview
• 14.2. South Korea Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Medicine Market

• 15.1. Western Europe Veterinary Medicine Market Overview
• 15.2. Western Europe Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Medicine Market

• 16.1. UK Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Medicine Market

• 17.1. Germany Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Medicine Market

• 18.1. France Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Medicine Market

• 19.1. Italy Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Medicine Market

• 20.1. Spain Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Medicine Market

• 21.1. Eastern Europe Veterinary Medicine Market Overview
• 21.2. Eastern Europe Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Medicine Market

• 22.1. Russia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Medicine Market

• 23.1. North America Veterinary Medicine Market Overview
• 23.2. North America Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Medicine Market

• 24.1. USA Veterinary Medicine Market Overview
• 24.2. USA Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Medicine Market

• 25.1. Canada Veterinary Medicine Market Overview
• 25.2. Canada Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Medicine Market

• 26.1. South America Veterinary Medicine Market Overview
• 26.2. South America Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Medicine Market

• 27.1. Brazil Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Medicine Market

• 28.1. Middle East Veterinary Medicine Market Overview
• 28.2. Middle East Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Medicine Market

• 29.1. Africa Veterinary Medicine Market Overview
• 29.2. Africa Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Medicine Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Medicine Market Competitive Landscape
• 30.2. Veterinary Medicine Market Company Profiles
  • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Dechra Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Medicine Market Other Major And Innovative Companies

• 31.1. Virbac
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Kindred Biosciences Inc.
• 31.4. Biogenesis Bago SA
• 31.5. Indian Immunologicals Limited
• 31.6. Neogen Corporation
• 31.7. Hester Biosciences Limited
• 31.8. Phibro Animal Health
• 31.9. Vetoquinol S.A.
• 31.10. IDEXX Laboratories Inc.
• 31.11. Heska Corporation
• 31.12. Henry Schein Animal Health
• 31.13. Patterson Companies Inc.
• 31.14. Covetrus Inc.
• 31.15. VetPartners

32. Global Veterinary Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Medicine Market

34. Recent Developments In The Veterinary Medicine Market

35. Veterinary Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer